Literature DB >> 18583471

Racial/Ethnic disparities in the use of nicotine replacement therapy and quit ratios in lifetime smokers ages 25 to 44 years.

Steven S Fu1, Molly M Kodl, Anne M Joseph, Dorothy K Hatsukami, Eric O Johnson, Naomi Breslau, Baolin Wu, Laura Bierut.   

Abstract

We examined racial/ethnic variations in the use of nicotine replacement therapy (NRT) and quit ratios among Caucasian, African American, Asian, and Latino lifetime smokers ages 25 to 44 years. We conducted cross-sectional analyses using data from individuals (n = 27,031) screened for enrollment in the Collaborative Study of the Genetics of Nicotine Dependence. Participants were randomly sampled from three Midwestern metropolitan areas using Health Maintenance Organization membership lists in Detroit, MI and Minneapolis, MN and a driver's license registry in St. Louis, MO from March 2003 to August 2005. A telephone survey collected information on smoking history, previous quit attempts, and sociodemographic characteristics. Among lifetime smokers (n = 9,216), univariate analysis indicated that African Americans (22%) and Latinos (22%) were significantly less likely to report having ever used NRT for smoking cessation than Caucasians (31%). Asians (22%) also reported lower rates of using NRT than Caucasians, but this difference was marginally significant (P = 0.06). These disparities persisted in multivariate analysis for African Americans [adjusted odds ratio (OR), 0.76; 95% confidence interval (95% CI), 0.63-0.91; P < 0.01] but not for Latinos (adjusted OR, 0.76; 95% CI, 0.54-1.06; P = 0.11) or Asians (adjusted OR, 0.98; 95% CI, 0.60-1.60; P = 0.95). As measured by the quit ratio, African Americans (35%) were less likely to have quit smoking than Caucasians (52%). This disparity persisted in multivariate logistic regression (adjusted OR, 0.66; 95% CI, 0.56-0.78; P < 0.001). Asian and Latino smokers were as likely as Caucasians to report smoking cessation. Future prospective studies are needed to assess whether lower utilization of cessation treatments such as NRT contribute to the observed disparity in quit ratios for African Americans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18583471      PMCID: PMC2593846          DOI: 10.1158/1055-9965.EPI-07-2726

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  29 in total

1.  Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status.

Authors:  Anne N Thorndike; Lois Biener; Nancy A Rigotti
Journal:  Am J Public Health       Date:  2002-03       Impact factor: 9.308

2.  Mentholated cigarettes and smoking cessation: findings from COMMIT. Community Intervention Trial for Smoking Cessation.

Authors:  A Hyland; S Garten; G A Giovino; K M Cummings
Journal:  Tob Control       Date:  2002-06       Impact factor: 7.552

3.  Do sex and ethnic differences in smoking initiation mask similarities in cessation behavior?

Authors:  Gene A McGrady; Linda L Pederson
Journal:  Am J Public Health       Date:  2002-06       Impact factor: 9.308

4.  Biochemical verification of tobacco use and cessation.

Authors: 
Journal:  Nicotine Tob Res       Date:  2002-05       Impact factor: 4.244

5.  Predictors of participation in a smoking cessation program among young adult smokers.

Authors:  Janet Audrain-McGovern; Chanita Hughes Halbert; Daniel Rodriguez; Leonard H Epstein; Kenneth P Tercyak
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03-02       Impact factor: 4.254

6.  Benefits of smoking cessation for longevity.

Authors:  Donald H Taylor; Vic Hasselblad; S Jane Henley; Michael J Thun; Frank A Sloan
Journal:  Am J Public Health       Date:  2002-06       Impact factor: 9.308

7.  Smoking cessation with and without assistance: a population-based analysis.

Authors:  S Zhu; T Melcer; J Sun; B Rosbrook; J P Pierce
Journal:  Am J Prev Med       Date:  2000-05       Impact factor: 5.043

Review 8.  Epidemiology of tobacco use in the United States.

Authors:  Gary A Giovino
Journal:  Oncogene       Date:  2002-10-21       Impact factor: 9.867

9.  Ten-year changes in smoking among young adults: are racial differences explained by socioeconomic factors in the CARDIA study?

Authors:  C I Kiefe; O D Williams; C E Lewis; J J Allison; P Sekar; L E Wagenknecht
Journal:  Am J Public Health       Date:  2001-02       Impact factor: 9.308

10.  Physicians' advice to quit smoking. The glass remains half empty.

Authors:  M P Doescher; B G Saver
Journal:  J Fam Pract       Date:  2000-06       Impact factor: 0.493

View more
  84 in total

Review 1.  A review of tobacco use treatments in U.S. ethnic minority populations.

Authors:  Lisa Sanderson Cox; Kolawole Okuyemi; Won S Choi; Jasjit S Ahluwalia
Journal:  Am J Health Promot       Date:  2011 May-Jun

2.  Evaluation of the brief questionnaire of smoking urges in Black light smokers.

Authors:  Rebecca L Clausius; Ron Krebill; Matthew S Mayo; Carrie Bronars; Laura Martin; Jasjit S Ahluwalia; Lisa Sanderson Cox
Journal:  Nicotine Tob Res       Date:  2012-01-12       Impact factor: 4.244

3.  Cancer prevention health services research: an emerging field.

Authors:  Hui Zhao; Jennifer H Tektiridis; Ning Zhang; Robert M Chamberlain
Journal:  J Cancer Educ       Date:  2012-05       Impact factor: 2.037

4.  The differential impact of nicotine replacement therapy sampling on cessation outcomes across established tobacco disparities groups.

Authors:  Jennifer Dahne; Amy E Wahlquist; Tracy T Smith; Matthew J Carpenter
Journal:  Prev Med       Date:  2020-04-19       Impact factor: 4.018

5.  Bupropion for smoking cessation in African American light smokers: a randomized controlled trial.

Authors:  Lisa Sanderson Cox; Nicole L Nollen; Matthew S Mayo; Won S Choi; Babalola Faseru; Neal L Benowitz; Rachel F Tyndale; Kolawole S Okuyemi; Jasjit S Ahluwalia
Journal:  J Natl Cancer Inst       Date:  2012-01-25       Impact factor: 13.506

6.  Effects of menthol on the pharmacokinetics of bupropion among Black smokers.

Authors:  Kolawole S Okuyemi; Babalola Faseru; Gregory A Reed; Lisa Sanderson Cox; Carrie A Bronars; Isaac Opole; Guy-Lucien Whembolua; Matthew S Mayo; Jasjit S Ahluwalia; Neal L Benowitz
Journal:  Nicotine Tob Res       Date:  2012-02-08       Impact factor: 4.244

7.  A pilot clinical trial of varenicline for smoking cessation in black smokers.

Authors:  Nicole L Nollen; Lisa Sanderson Cox; Niaman Nazir; Edward F Ellerbeck; Ashli Owen; Sydni Pankey; Nia Thompson; Jasjit S Ahluwalia
Journal:  Nicotine Tob Res       Date:  2011-04-15       Impact factor: 4.244

8.  A nationwide analysis of US racial/ethnic disparities in smoking behaviors, smoking cessation, and cessation-related factors.

Authors:  Dennis R Trinidad; Eliseo J Pérez-Stable; Martha M White; Sherry L Emery; Karen Messer
Journal:  Am J Public Health       Date:  2011-02-17       Impact factor: 9.308

9.  Predictors of cessation pharmacotherapy use among black and non-Hispanic white smokers.

Authors:  Katherine K Ryan; Elizabeth Garrett-Mayer; Anthony J Alberg; Kathleen B Cartmell; Matthew J Carpenter
Journal:  Nicotine Tob Res       Date:  2011-04-04       Impact factor: 4.244

10.  Personalized medicine and tobacco-related health disparities: is there a role for genetics?

Authors:  Chris Carlsten; Abigail Halperin; Julia Crouch; Wylie Burke
Journal:  Ann Fam Med       Date:  2011 Jul-Aug       Impact factor: 5.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.